Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claude Le Feuvre

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Presse Medicale (Paris, France : 1983)|April 14, 2009
[Coronary artery disease in patients with diabetes]Claude Le Feuvre
Presse Medicale (Paris, France : 1983)|October 3, 2012
[The States General to a cardiac plan]Claude Le Feuvre
Presse Medicale (Paris, France : 1983)|July 17, 2004
[Cardiovascular effects of rosiglitazone]Claude Le Feuvre
La Revue Du Praticien|April 28, 2004
[Aortic regurgitation]Christophe Tribouilloy, Thomas Goissen, Claude Le Feuvre
Diabetes Care|May 29, 2010
Screening of silent myocardial ischemia in type 2 diabetic patients: a randomized trial comparing isotopic and echocardiographic stress testsSophie Jacqueminet, Olivier Barthélémy, Claude Le Feuvre
The New England Journal of Medicine|January 27, 2018
Rivaroxaban in Stable Cardiovascular DiseaseGérard Helft, Claude Le Feuvre, Azfar Zaman
Future Cardiology|April 2, 2011
Myocardial ischemia: a silent epidemic in Type 2 diabetes patientsClaude Le Feuvre, Sophie Jacqueminet, Olivier Barthelemy
Archives of Cardiovascular Diseases|July 29, 2008
Left ventricular aneurysm in Behçet's diseaseGérard Helft, Claude Le Feuvre, Bertrand Wechsler
Arquivos Brasileiros De Endocrinologia E Metabologia|May 17, 2007
Silent myocardial ischemia screening in patients with diabetes mellitusOlivier Barthelemy, Claude Le Feuvre, José Timsit
Nature Clinical Practice. Cardiovascular Medicine|November 24, 2006
Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulationGérard Helft, Martine Gilard, Claude Le Feuvre, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Presse Medicale (Paris, France : 1983)|April 14, 2009
[Coronary artery disease in patients with diabetes]Claude Le Feuvre
Presse Medicale (Paris, France : 1983)|October 3, 2012
[The States General to a cardiac plan]Claude Le Feuvre
Presse Medicale (Paris, France : 1983)|July 17, 2004
[Cardiovascular effects of rosiglitazone]Claude Le Feuvre
La Revue Du Praticien|April 28, 2004
[Aortic regurgitation]Christophe Tribouilloy, Thomas Goissen, Claude Le Feuvre
Diabetes Care|May 29, 2010
Screening of silent myocardial ischemia in type 2 diabetic patients: a randomized trial comparing isotopic and echocardiographic stress testsSophie Jacqueminet, Olivier Barthélémy, Claude Le Feuvre
The New England Journal of Medicine|January 27, 2018
Rivaroxaban in Stable Cardiovascular DiseaseGérard Helft, Claude Le Feuvre, Azfar Zaman
Future Cardiology|April 2, 2011
Myocardial ischemia: a silent epidemic in Type 2 diabetes patientsClaude Le Feuvre, Sophie Jacqueminet, Olivier Barthelemy
Archives of Cardiovascular Diseases|July 29, 2008
Left ventricular aneurysm in Behçet's diseaseGérard Helft, Claude Le Feuvre, Bertrand Wechsler
Arquivos Brasileiros De Endocrinologia E Metabologia|May 17, 2007
Silent myocardial ischemia screening in patients with diabetes mellitusOlivier Barthelemy, Claude Le Feuvre, José Timsit
Nature Clinical Practice. Cardiovascular Medicine|November 24, 2006
Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulationGérard Helft, Martine Gilard, Claude Le Feuvre, et al.
Pageof 5